DR. NEIL CLAYTON BODICK
Osteopathic Medicine at Oakmont Ln, Indianapolis, IN
License number
Indiana 01042005A
Category
Osteopathic Medicine
Type
Family Medicine
License number
Indiana 01042005A
Category
Osteopathic Medicine
Type
Adult Medicine
Address
Address
8517 Oakmont Ln, Indianapolis, IN 46260
Phone
(317) 251-6092
Professional information
Dr. Neil C Bodick, Indianapolis IN - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
8517 Oakmont Ln, Indianapolis 46260
7563 E 100 S, Whitestown 46075
7563 E 100 S, Whitestown 46075
Languages:
English
Education:
Medical School
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1983
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1983
Method For Treating Anxiety
US Patent:
5484794, Jan 16, 1996
Filed:
Nov 9, 1994
Appl. No.:
8/336589
Inventors:
Neil C. Bodick - Indianapolis IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A01N 4390, A61K 3144, C07D45302
US Classification:
514305
Abstract:
The present invention provides a method for treating anxiety in humans using heterocyclic compounds.
Method For Treating Anxiety
US Patent:
5852036, Dec 22, 1998
Filed:
May 23, 1995
Appl. No.:
8/448278
Inventors:
Neil C. Bodick - Indianapolis IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3144
US Classification:
514299
Abstract:
The present invention provides a method for treating anxiety in humans using compounds which modulate a muscarinic receptor.
Method For Treating Anxiety
US Patent:
5574028, Nov 12, 1996
Filed:
Oct 31, 1994
Appl. No.:
8/333088
Inventors:
Neil C. Bodick - Indianapolis IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31395
US Classification:
514210
Abstract:
The present invention provides a method for treating anxiety in a human in need thereof, comprising administering to the human an antianxiety amount of a muscarinic agonist compound of the general formula ##STR1## wherein Z is a 5-membered heterocyclic ring as defined in the disclosure.
Method For Treating Anxiety
US Patent:
5726193, Mar 10, 1998
Filed:
May 24, 1995
Appl. No.:
8/449165
Inventors:
Neil C. Bodick - Indianapolis IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A01N 4382
US Classification:
514362
Abstract:
The present invention provides a method for treating anxiety in humans using heterocyclic compounds.
Method For Treating Anxiety
US Patent:
5708014, Jan 13, 1998
Filed:
Nov 9, 1994
Appl. No.:
8/336454
Inventors:
Neil C. Bodick - Indianapolis IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3144
US Classification:
514340
Abstract:
The present invention provides a method for treating anxiety in humans using of Formula I herein disclosed compounds.
Method For Treating Anxiety
US Patent:
5488056, Jan 30, 1996
Filed:
Oct 31, 1994
Appl. No.:
8/332186
Inventors:
Neil C. Bodick - Indianapolis IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3144, C07D45302
US Classification:
514305
Abstract:
The present invention provides a method for treating anxiety in humans using heterocyclic compounds.
Method For Treating Anxiety
US Patent:
5763457, Jun 9, 1998
Filed:
Oct 22, 1996
Appl. No.:
8/735300
Inventors:
Neil C. Bodick - Indianapolis IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3144, A61K 31395, A61K 3155, A61K 31445, A61K 3141
US Classification:
514305
Abstract:
The present invention relates a method for treating anxiety using azacyclic and azabicyclic oxadiazole compounds.
Method For Treating Anxiety
US Patent:
5852037, Dec 22, 1998
Filed:
Oct 22, 1996
Appl. No.:
8/735359
Inventors:
Neil C. Bodick - Indianapolis IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Franklin P. Bymaster - Brownsburg IN
Walter W. Offen - Indianapolis IN
Harlan E. Shannon - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3144, A61K 3141, A61K 3142, A61K 3145
US Classification:
514305
Abstract:
The present invention provides a method for treating anxiety in humans using azacyclic or azabicyclic compounds.
Method For Treating Excessive Aggression
US Patent:
6090829, Jul 18, 2000
Filed:
Dec 16, 1998
Appl. No.:
9/202518
Inventors:
Neil C Bodick - Indianapolis IN
Franklin P Bymaster - Brownsburg IN
Harlan E Shannon - Carmel IN
Franklin P Bymaster - Brownsburg IN
Harlan E Shannon - Carmel IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 314406, A61K 314436, A61K 314439
US Classification:
514342
Abstract:
The present invention provides a method of treating conduct disorder in a human using a compound of formula (I) ##STR1##.